Rheumatology[journal] 检索结果

1. The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.

作者: Anshuman P Malaviya.;Jo Ledingham.;Jill Bloxham.;Aisla Bosworth.;Maya Buch.;Ernest Choy.;Andrew Cope.;John Isaacs.;David Marshall.;Gary Wright.;Andrew J K Ostör.; .; .
来源: Rheumatology (Oxford). 2014年53卷7期1344-6页

2. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.

作者: Eleana Ntatsaki.;David Carruthers.;Kuntal Chakravarty.;David D'Cruz.;Lorraine Harper.;David Jayne.;Raashid Luqmani.;John Mills.;Janice Mooney.;Michael Venning.;Richard A Watts.; .
来源: Rheumatology (Oxford). 2014年53卷12期2306-9页

3. The Italian MSUS Study Group recommendations for the format and content of the report and documentation in musculoskeletal ultrasonography in rheumatology.

作者: Annamaria Iagnocco.;Francesco Porta.;Giovanna Cuomo.;Andrea Delle Sedie.;Emilio Filippucci.;Walter Grassi.;Garifallia Sakellariou.;Oscar Epis.;Antonella Adinolfi.;Fulvia Ceccarelli.;Orazio De Lucia.;Luca Di Geso.;Valentina Di Sabatino.;Alessandra Gabba.;Angelica Gattamelata.;Marwin Gutierrez.;Laura Massaro.;Marco Massarotti.;Carlo Perricone.;Valentina Picerno.;Viviana Ravagnani.;Lucrezia Riente.;Crescenzio Scioscia.;Esperanza Naredo.;Georgios Filippou.; .
来源: Rheumatology (Oxford). 2014年53卷2期367-73页

The objective of this study was to draw up a set of recommendations for the format and content of the musculoskeletal ultrasonography (MSUS) report in rheumatology.

4. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.

作者: Laura C Coates.;William Tillett.;David Chandler.;Philip S Helliwell.;Eleanor Korendowych.;Stuart Kyle.;Iain B McInnes.;Susan Oliver.;Anthony Ormerod.;Catherine Smith.;Deborah Symmons.;Nicola Waldron.;Neil J McHugh.; .
来源: Rheumatology (Oxford). 2013年52卷10期1754-7页

5. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.

作者: Marwan Bukhari.;Rikki Abernethy.;Chris Deighton.;Tina Ding.;Kimme Hyrich.;Mark Lunt.;Raashid Luqmani.;Patrick Kiely.;Ailsa Bosworth.;Jo Ledingham.;Andrew Ostör.;Kate Gadsby.;Frank McKenna.;Diana Finney.;Josh Dixey.; .
来源: Rheumatology (Oxford). 2011年50卷12期2311-3页

6. BSR and BHPR guidelines for the management of polymyalgia rheumatica.

作者: Bhaskar Dasgupta.;Frances A Borg.;Nada Hassan.;Kevin Barraclough.;Brian Bourke.;Joan Fulcher.;Jane Hollywood.;Andrew Hutchings.;Valerie Kyle.;Jennifer Nott.;Michael Power.;Ash Samanta.; .
来源: Rheumatology (Oxford). 2010年49卷1期186-90页

7. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).

作者: Raashid Luqmani.;Sheena Hennell.;Cristina Estrach.;Damian Basher.;Fraser Birrell.;Ailsa Bosworth.;Frank Burke.;Carole Callaghan.;Jaime Candal-Couto.;Chris Fokke.;Nicola Goodson.;Dawn Homer.;John Jackman.;Paula Jeffreson.;Susan Oliver.;Mike Reed.;Luis Sanz.;Zoe Stableford.;Peter Taylor.;Nick Todd.;Louise Warburton.;Chris Washbrook.;Mark Wilkinson.; .; .
来源: Rheumatology (Oxford). 2009年48卷4期436-9页

8. American College of Rheumatology recommendations for the treatment of RA: an issue of choices.

作者: Robert B M Landewé.
来源: Nat Clin Pract Rheumatol. 2009年5卷1期8-9页

9. Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw.

作者: Philip N Sambrook.
来源: Nat Clin Pract Rheumatol. 2009年5卷1期6-7页

10. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.

作者: E R Soriano.;C Galarza-Maldonado.;M H Cardiel.;B A Pons-Estel.;L Massardo.;C V Caballero-Uribe.;A F Achurra-Castillo.;L A Barile-Fabris.;J Chávez-Corrales.;J F Díaz-Coto.;M H Esteva-Spinetti.;M Guibert-Toledano.;F Irazoque Palazuelos.;M W Keiserman.;A V Lomonte.;L M H Mota.;C Pineda Villaseñor.;G S Alarcón.; .
来源: Rheumatology (Oxford). 2008年47卷7期1097-9页

11. Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.

作者: D E Furst.;R J Halbert.;C O Bingham.;S Fukudome.;L Anderson.;P Bonafede.;V Bray.;S B Cohen.;Y R S Sherrer.;E W S St Clair.;J R P Tesser.;M Weinblatt.;R W Dubois.
来源: Rheumatology (Oxford). 2008年47卷2期194-9页

There is a lack of agreement on assessing disease activity in patients with RA and determining when the RA treatment should be changed or continued. A panel of rheumatologists was convened to develop guidelines to assess adequacy of disease control, focusing on the use of disease-modifying anti-rheumatic drugs.

12. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

作者: C Lapraik.;R Watts.;P Bacon.;D Carruthers.;K Chakravarty.;D D'Cruz.;L Guillevin.;L Harper.;D Jayne.;R Luqmani.;J Mooney.;D Scott.; .
来源: Rheumatology (Oxford). 2007年46卷10期1615-6页

13. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

作者: Kelsey M Jordan.;J Stewart Cameron.;Michael Snaith.;Weiya Zhang.;Michael Doherty.;Jonathan Seckl.;Aroon Hingorani.;Richard Jaques.;George Nuki.; .
来源: Rheumatology (Oxford). 2007年46卷8期1372-4页

14. Provisional guidelines for applying the Department of Health (England) 18-week-patient pathway to specialist rheumatology care.

作者: D A Walsh.;C Kelly.;A Bosworth.;C Price.;G Burbage.
来源: Rheumatology (Oxford). 2007年46卷7期1200-6页

The Government Department of Health (England) has set a target that by 2008 patients on pathways that do or may involve medical or surgical consultant-led care should wait no longer than 18 weeks from referral to start of definitive treatment. Department of Health guidance must be interpreted and applied to patients with rheumatological problems.

15. Development of a competency framework for general practitioners with a special interest in musculoskeletal/rheumatology practice.

作者: E M Hay.;A Campbell.;S Linney.;E Wise.; .
来源: Rheumatology (Oxford). 2007年46卷2期360-2页

16. Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: guidance for BSPAR members--executive summary.

作者: H Foster.;J Davidson.;E Baildam.;M Abinun.;L R Wedderburn.; .
来源: Rheumatology (Oxford). 2006年45卷12期1570-1页

17. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.

作者: K Chakravarty.;H McDonald.;T Pullar.;A Taggart.;R Chalmers.;S Oliver.;J Mooney.;M Somerville.;A Bosworth.;T Kennedy.; .; .
来源: Rheumatology (Oxford). 2008年47卷6期924-5页

18. British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).

作者: R Luqmani.;S Hennell.;C Estrach.;F Birrell.;A Bosworth.;G Davenport.;C Fokke.;N Goodson.;P Jeffreson.;E Lamb.;R Mohammed.;S Oliver.;Z Stableford.;D Walsh.;C Washbrook.;F Webb.; .; .
来源: Rheumatology (Oxford). 2006年45卷9期1167-9页

19. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults.

作者: G Coakley.;C Mathews.;M Field.;A Jones.;G Kingsley.;D Walker.;M Phillips.;C Bradish.;A McLachlan.;R Mohammed.;V Weston.; .
来源: Rheumatology (Oxford). 2006年45卷8期1039-41页

20. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.

作者: A Keat.;N Barkham.;A Bhalla.;K Gaffney.;H Marzo-Ortega.;S Paul.;F Rogers.;M Somerville.;R Sturrock.;P Wordsworth.; .
来源: Rheumatology (Oxford). 2005年44卷7期939-47页

结果排序

文献格式

出版时间

出版类型

出版语言